Lymphatic Vessel Activation in Cancer
暂无分享,去创建一个
[1] I. Werner. Medical Therapy of Breast Cancer , 2008 .
[2] A. Ruddell,et al. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis , 2008, Oncogene.
[3] K. Miyazono,et al. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. , 2007, Cancer research.
[4] E. van Marck,et al. Increased Sentinel Lymph Node Lymphangiogenesis is Associated with Nonsentinel Axillary Lymph Node Involvement in Breast Cancer Patients with a Positive Sentinel Node , 2007, Clinical Cancer Research.
[5] R. Nibbs,et al. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. , 2007, The Journal of clinical investigation.
[6] S. Lo,et al. Survival predictors in patients with node‐negative gastric carcinoma , 2007, Journal of gastroenterology and hepatology.
[7] J. Nährig,et al. Sentinel Lymph Node Biopsy in Colon Cancer: A Prospective Multicenter Trial , 2007, Annals of surgery.
[8] D. Bates,et al. Chemokine-mediated migration of melanoma cells towards lymphatics – a mechanism contributing to metastasis , 2007, Oncogene.
[9] L. Forrest,et al. Prediction in breast cancer of the extent of axillary node involvement from the size and lymphovascular invasion status of the primary tumour: medico-legal considerations. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[10] T. Veikkola,et al. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. , 2007, The American journal of pathology.
[11] N. Baxter,et al. Association versus causation versus quality improvement: setting benchmarks for lymph node evaluation in colon cancer. , 2007, Journal of the National Cancer Institute.
[12] M. May,et al. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens , 2007, BJU international.
[13] K. Alitalo,et al. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. , 2007, Blood.
[14] A. Ruddell,et al. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. , 2007, The American journal of pathology.
[15] S. Fox,et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours , 2006, British Journal of Cancer.
[16] B. Berghuis,et al. Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. , 2006, Cancer research.
[17] M. Rivera,et al. Issues Relating to Lymphovascular Invasion in Breast Carcinoma , 2006, Advances in anatomic pathology.
[18] E. van Marck,et al. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer , 2006, British Journal of Cancer.
[19] R. Elashoff,et al. Sentinel-node biopsy or nodal observation in melanoma. , 2006, The New England journal of medicine.
[20] Dai Fukumura,et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. , 2006, Cancer research.
[21] I. Thompson,et al. Current status of lymph node‐positive prostate cancer , 2006, Cancer.
[22] M. Gnant,et al. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. , 2006, Surgery.
[23] Y. Lotan,et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Jen-Hao Chen,et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. , 2006, The Lancet. Oncology.
[25] F. Ginhoux,et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. , 2006, Immunity.
[26] R W Blamey,et al. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. , 2006, European journal of cancer.
[27] J. Listgarten,et al. Lymphovascular Invasion Is Associated With Poor Survival in Gastric Cancer: An Application of Gene-Expression and Tissue Array Techniques , 2006, Annals of Surgery.
[28] Haiqun Lin,et al. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. , 2005, The Journal of urology.
[29] D. Kerjaschki. The crucial role of macrophages in lymphangiogenesis. , 2005, The Journal of clinical investigation.
[30] Yihai Cao. Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis , 2005, Nature Reviews Cancer.
[31] Jinping Li,et al. Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway , 2005, Oncogene.
[32] S. Groshen,et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. , 2005, The Journal of urology.
[33] B. Konety,et al. Effect of axillary lymphadenectomy on breast carcinoma survival , 2005, Breast Cancer Research and Treatment.
[34] Satoshi Hirakawa,et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis , 2005, The Journal of experimental medicine.
[35] Antonio Alcami,et al. The chemokine receptor D6 limits the inflammatory response in vivo , 2005, Nature Immunology.
[36] K. Alitalo,et al. Loss of Neural Cell Adhesion Molecule Induces Tumor Metastasis by Up-regulating Lymphangiogenesis , 2004, Cancer Research.
[37] Dai Fukumura,et al. Peritumor Lymphatics Induced by Vascular Endothelial Growth Factor-C Exhibit Abnormal Function , 2004, Cancer Research.
[38] D. Gouma,et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] J. Tille,et al. Lymphangiogenesis and tumor metastasis , 2003, Thrombosis and Haemostasis.
[40] P. Heikkilä,et al. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. , 2003, Cancer research.
[41] Donglei Zhang,et al. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. , 2003, Cancer research.
[42] S. Jalkanen,et al. The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels , 2003, European journal of immunology.
[43] J. Sleeman,et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. , 2003, Cancer research.
[44] M. Skobe,et al. Therapeutic lymphangiogenesis with human recombinant VEGF‐C , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] M. Skobe,et al. Lymphatic Vessel Activation in Cancer , 2002, Annals of the New York Academy of Sciences.
[46] M. Skobe,et al. Molecular characterization of lymphatic endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] I. Olivotto,et al. Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer. , 2002, International journal of radiation oncology, biology, physics.
[48] M. Karkkainen,et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. , 2002, Development.
[49] K. Alitalo,et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factor , 2002, The EMBO journal.
[50] K. Alitalo,et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.
[51] K. Alitalo,et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. , 2002, Journal of the National Cancer Institute.
[52] R. Jain,et al. Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. , 2002, Journal of the National Cancer Institute.
[53] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[54] K. Alitalo,et al. VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors , 2002, International journal of cancer.
[55] M. Detmar,et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype , 2002, The EMBO journal.
[56] R. Jain,et al. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? , 2002, Journal of the National Cancer Institute.
[57] Adrian L Harris,et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. , 2002, Cancer research.
[58] R. Jain,et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. , 2001, Cancer Research.
[59] H. Wiley,et al. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. , 2001, Journal of the National Cancer Institute.
[60] S. Jalkanen,et al. Mannose Receptor Is a Novel Ligand for L-Selectin and Mediates Lymphocyte Binding to Lymphatic Endothelium , 2001, The Journal of experimental medicine.
[61] J. Sleeman,et al. Markers for the lymphatic endothelium: In search of the holy grail? , 2001, Microscopy research and technique.
[62] J. Sleeman,et al. Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane , 2001, Microscopy research and technique.
[63] M. Skobe,et al. Lymphatic function, lymphangiogenesis, and cancer metastasis , 2001, Microscopy research and technique.
[64] R. Kauppinen,et al. A model for gene therapy of human hereditary lymphedema , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[65] D. Kerjaschki,et al. Isolation and Characterization of Dermal Lymphatic and Blood Endothelial Cells Reveal Stable and Functionally Specialized Cell Lineages , 2001, The Journal of experimental medicine.
[66] M. Skobe,et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. , 2001, The American journal of pathology.
[67] M. Nosrati,et al. Vascular involvement in the prognosis of primary cutaneous melanoma. , 2001, Archives of dermatology.
[68] T. Furuhata,et al. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. , 2001, Journal of experimental & clinical cancer research : CR.
[69] J. Brierley,et al. Local excision and postoperative radiotherapy for distal rectal cancer. , 2001, International journal of radiation oncology, biology, physics.
[70] S. Breiteneder-Geleff,et al. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. , 2001, Anticancer research.
[71] D. Ruiter,et al. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. , 2001, Investigative ophthalmology & visual science.
[72] D. Kerjaschki,et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. , 2001, The American journal of pathology.
[73] L. Orci,et al. Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis , 2001, The EMBO journal.
[74] Steven A. Stacker,et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.
[75] Thomas Hawighorst,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.
[76] P. Tanis,et al. History of sentinel node and validation of the technique , 2001, Breast Cancer Research.
[77] M. Schindl,et al. Lymphatic microvessel density as a novel prognostic factor in early‐stage invasive cervical cancer , 2001, International journal of cancer.
[78] G. Martiny-Baron,et al. Active interaction of human A375 melanoma cells with the lymphatics in vivo , 2000, Histochemistry and Cell Biology.
[79] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[80] Y. Maehara,et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues , 2000, British Journal of Cancer.
[81] M. Schindl,et al. Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. , 2000, Anticancer research.
[82] R. Jain,et al. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. , 2000, Cancer research.
[83] S. Hirohashi,et al. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[84] A. Eggert,et al. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[85] J. Vaillant,et al. Vegf, vegf‐B, vegf‐C and their receptors KDR, FLT‐1 and FLT‐4 during the neoplastic progression of human colonic mucosa , 2000, International journal of cancer.
[86] D. Birnbaum,et al. VEGFc and VEGFR3 expression in human thyroid pathologies , 2000, International journal of cancer.
[87] M. Oda,et al. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. , 2000, The Journal of thoracic and cardiovascular surgery.
[88] T. Obara,et al. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. , 1999, Surgery.
[89] L. Mariani,et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. , 1999, The American journal of pathology.
[90] T. Kawarabayashi,et al. The grading of lymphovascular space invasion in endometrial carcinoma , 1999, Cancer.
[91] R. K. Bright,et al. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours , 1999, British Journal of Cancer.
[92] J. Kurebayashi,et al. Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer , 1999, Japanese journal of cancer research : Gann.
[93] Takuma Sasaki,et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[94] K. Alitalo,et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis , 1999, British Journal of Cancer.
[95] K. Alitalo,et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. , 1998, The American journal of pathology.
[96] E. Tschachler,et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. , 1998, Cancer research.
[97] K. Alitalo,et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[98] S. Ergün,et al. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia , 1997, Leukemia.
[99] Yihai Cao,et al. Proteolytic processing regulates receptor specificity and activity of VEGF‐C , 1997, The EMBO journal.
[100] K. Alitalo,et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia , 1997, Oncogene.
[101] L. Akslen,et al. Independent prognostic importance of vascular invasion in nodular melanomas , 1996, Cancer.
[102] Benoit Vf. Clinical problem-solving: if at first you don't succeed. , 1996 .
[103] W. Wood,et al. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[104] K. Alitalo,et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[105] B. Zetter,et al. Adhesion molecules in tumor metastasis. , 1993, Seminars in cancer biology.
[106] D L Morton,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.
[107] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[108] Rakesh K. Jain,et al. Vascular and interstitial barriers to delivery of therapeutic agents in tumors , 1990, Cancer and Metastasis Reviews.
[109] G. Schmid-Schönbein,et al. Microlymphatics and lymph flow. , 1990, Physiological reviews.
[110] F. Hartveit. Attenuated cells in breast stroma: the missing lymphatic system of the breast , 1990, Histopathology.
[111] T. Ryan,et al. Structure and function of lymphatics. , 1989, The Journal of investigative dermatology.
[112] Geert W. Schmid-Schönbein,et al. Biomechanical interactions of cancer cells with the microvasculature during metastasis , 1989, Cell Biophysics.
[113] L. Leak. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. , 1970, Microvascular research.
[114] I. Zeidman. Experimental studies on the spread of cancer in the lymphatic system. III. Tumor emboli in thoracic duct; the pathogenesis of Virchow's node. , 1955, Cancer research.
[115] R. Gilchrist,et al. Surgical management of advanced cancer of the breast. , 1950, A.M.A. archives of surgery.
[116] R. Tilghman,et al. LYMPH VESSELS IN RABBIT CARCINOMA: WITH A NOTE ON THE NORMAL LYMPH VESSEL STRUCTURE OF THE TESTIS , 1933 .
[117] F. L. Reichert. THE REGENERATION OF THE LYMPHATICS , 1926 .
[118] J. Kim,et al. Genetic and Pathologic Changes associated with Lymphovascular Invasion of Colorectal Adenocarcinoma , 2005, Clinical & Experimental Metastasis.
[119] M. Witte,et al. Lymphangiogenesis: mechanisms, significance and clinical implications. , 1997, EXS.
[120] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. , 1996, The EMBO journal.
[121] C. Balch. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.